New pill aims to keep pneumonia patients out of hospital
Disease control
Terminated
This study tested whether adding an experimental drug called silmitasertib to standard care could help adults with pneumonia caused by COVID-19 or the flu. The goal was to see if the combination treatment could prevent patients from getting worse and needing to go to the hospital…
Phase: PHASE2 • Sponsor: Senhwa Biosciences, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC